News

Gladstone in the News October 18, 2020

Conservatives Confront Moral Dilemma of Vaccines and Treatments Derived from Fetal Tissue Cells

abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.

Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Article May 8, 2020

Roddenberry Foundation Donates $1 Million to Support Gladstone COVID-19 Research

This generous gift will support Gladstone scientists who are pivoting their ongoing work to help fight the COVID-19 pandemic.

Donor Stories COVID-19 Roddenberry Stem Cell Center Srivastava Lab

Gladstone in the News April 7, 2020

Tackling Heart Disease

The Stem Cell Podcast—Gladstone President Deepak Srivastava describes his work using human induced pluripotent stem cells to investigate the gene networks that dictate cell fate decisions, and how this research could lead to therapeutics for congenital heart disease and heart failure. He also describes the importance of stem cell research in fighting the COVID-19 pandemic.

Gladstone Experts COVID-19 Heart Failure Congenital Heart Disease Cardiovascular Disease Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Article November 11, 2019

Gordon Keller: Laying a Foundation for Stem Cell Therapeutics

Gordon Keller, recipient of the 2019 Ogawa-Yamanaka Stem Cell Prize, discusses challenges and successes during his 30 years of pioneering research on stem cells.

Ogawa Stem Cell Prize Profile Roddenberry Stem Cell Center Stem Cells/iPSCs

Article July 3, 2018

Roddenberry Gift Ushers Gladstone Stem Cell Research into the Future

The path to medical breakthroughs lies in bold, ambitious science

Donor Stories Institutional News Spinal Cord Injuries Alzheimer’s Disease Diabetes Roddenberry Stem Cell Center Bruneau Lab Ding Lab Huang Lab McDevitt Lab

Article February 4, 2015

Improving Genome Editing with Drugs

The first study to manipulate CRISPR genome editing using small molecules has important implications for correcting disease-causing genetic mutations

Cardiovascular Disease Roddenberry Stem Cell Center Ding Lab CRISPR/Gene Editing Stem Cells/iPSCs